Skip to content
healthcare.dev

Sulfasalazine

NDC 16571-261, Sulfasalazine, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-261
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219046
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-261 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SULFASALAZINE500 mg/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
16571-261-0116571026101100 TABLET in 1 CONTAINER (16571-261-01)
16571-261-3016571026130300 TABLET in 1 CONTAINER (16571-261-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3254432e-87a4-4af0-afd1-d9e6f1b0efd4

Use it

Look up 16571-261 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-261 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-261. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.